Home
Business & Finance
Markets
Markets
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
SUPERNUS PHARM
(NQ:
SUPN
)
6.670
USD
+0.020 (+0.30%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
6.610
Bid (Size)
6.660 (1700)
Ask (Size)
6.680 (4200)
Prev. Close
6.650
Today's Range
6.500 - 6.780
52wk Range
4.450 - 16.68
Shares Outstanding
30,985,416
Dividend Yield
N/A
Top News
More News
Commit To Purchase Supernus Pharmaceuticals At $5, Earn 17% Annualized
June 11, 2013
Investors considering a purchase of Supernus Pharmaceuticals Inc (SUPN) stock, but cautious about paying the going market price of $6.81/share, might benefit from considering selling puts among the...
Read More
category
Dividends
from
Dividend Channel
Commit To Purchase Supernus Pharmaceuticals At $5, Earn 17% Annualized
June 11, 2013
Investors considering a purchase of Supernus Pharmaceuticals Inc (SUPN) stock, but cautious about paying the going market price of $6.81/share, might benefit from considering selling puts among the...
Read More
category
Stocks
from
Market News Video
More News
Read More
StreetInsider.com Pre-Open Movers 6/10: (STEL) (CSIQ) (SUPN) Higher; (DVAX) (ROVI) (EAC) Lower (more...)
June 10, 2013
from
StreetInsider.com News Articles
Supernus (SUPN) Receives Tentative FDA Approval of Trokendi XR
June 10, 2013
from
StreetInsider.com News Articles
Supernus Receives Tentative Approval for Trokendi XR(TM)
June 10, 2013
from
GlobeNewswire News Releases
Bio-Wire Equity Surveillance – Closing Bell 6/3/2013
June 04, 2013
category
INFI
,
RIGL
,
Bio/Wire
, and 5 more.
from
Bio-Wire.Com
Notable Short Interest Changes In 4 Select NASDAQ Biotechs
May 29, 2013
category
SUPN
,
SPPI
,
QCOR
, and 2 more.
from
Bio-Wire.Com
Supernus to Present at Two Investor Conferences
May 20, 2013
from
GlobeNewswire News Releases
Supernus Shorts See Losses, Dendreon Shorts Extend Gains
May 20, 2013
category
SUPN
,
Bio/Wire
,
DNDN
from
Bio-Wire.Com
Supernus (SUPN) PT Trimmed at Jefferies, But Survey Shows Significant Market Opportunity
May 17, 2013
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Markets
Home
Business & Finance
Markets
©2013 About.com.